Investor Alert

Dow Jones Newswires Archives | Email alerts

Sept. 26, 2022, 6:00 p.m. EDT

DOJ Says Biogen in Settlement; Agreement-in-Principle Previously Disclosed

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

By Josh Beckerman

The Justice Department said Biogen Inc. agreed to pay $900 million to resolve allegations that it caused the submission of false claims to Medicare and Medicaid by allegedly paying kickbacks to doctors.

In its second-quarter earnings report in July, Biogen said it recorded $900 million related to an agreement in principle to resolve the litigation. It said the agreement in principle didn't include any admission of liability and was subject to negotiation of final settlement agreements and documents.

The DOJ said Biogen will pay $843.8 million to the U.S. and $56.2 million to 15 states. Former Biogen employee Michael Bawduniak, who sued the company, will receive about 29.6% of the federal proceeds.

Write to Josh Beckerman at josh.beckerman@wsj.com

Get news alerts on Biogen Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Dow Jones Newswires

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.